Document is current
Any future updates will be listed below
-
Authors
Anneberg, Olivia Mariella https://orcid.org/0009-0007-7816-2455
Olsen, Sjurdur Frodi
Hansen, Anne Vinkel https://orcid.org/0000-0003-4523-3521
Julsgaard, Mette
Bjerregaard, Anne Ahrendt
Halldorsson, Thorhallur Ingi
Jess, Tine https://orcid.org/0000-0002-4391-7332
De Freitas, Maiara Brusco
-
Funding
Funding for this research was provided by:
Danmarks Grundforskningsfond (DNRF148)
European Crohn's and Colitis Organisation D-ECCO Grant
- License Information
-
More Information
Article History
Received: 15 July 2025
Accepted: 10 December 2025
First Online: 29 December 2025
Competing interests
: MJ has received consulting/advisory board fees from Ferring, Takeda, AbbVie, PharmaCosmos and Tillots Pharma; speaker’s fees from Tillotts Pharma, MSD, Ferring and Takeda. TJ has received consultancy fees from Ferring and Pfizer. MJ has received research grants for other investigator-driven studies from Takeda, and the Novo Nordisk Foundation (NNF23Oc0081717). All other authors declare no competing interests. The authors declare that there are no other financial or non-financial relationships or activities that could appear to have influenced the submitted work.
